Cybin Inc. CYBN, a clinical-stage biopharma company developing innovative psychedelic-based treatment options, is launching a free online facilitation training course.
EMBARK Open Access, an open and foundational online course, is aimed at healthcare professionals and those interested in offering psychological support.
CEO Doug Drysdale says the company’s mission to revolutionize mental healthcare is joined by its commitment to supporting the entire ecosystem.
“By offering a cost-free facilitator training program, we hope to promote accessible, scalable, and most importantly, ethical psychological support during psychedelic-assisted therapy,” he said.
The psychedelics facilitation model, EMBARK, has a new series of 12 video-based training modules and accompanying exercises as well as a new website.
Upon completing EMBARK OA, participants will receive a record of completion, which can be used as a bridge for facilitators to be enrolled in upcoming EMBARK training programs and potential participation in Cybin-sponsored clinical studies.
EMBARK’s co-creator Dr. Alex Belser says training is “facing a bottleneck,” with programs being expensive and out of reach for many.
These challenges have propelled the launch of EMBARK OA. “Our team has put a lot of thoughtful, science-informed, and heartfelt work into these training materials, and we are proud to share them with the broader healthcare community. Our hope is to provide more equitable access to high-quality learning and development in psychedelic practice,” Belser concluded.
Benzinga’s Psychedelics Capital Conference
April 13th at the Fontainebleau Miami Beach Hotel will be THE place to set up deals, raise money, meet investors and key partners, and learn from the industry’s greatest.
One more day to go… Get your tickets NOW and don’t miss out!
Photo by Glenn Carstens-Peters on Unsplash
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!